Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 06 Mar 2023
USA: The syrup drug Diethylene glycol (DEG), a drug commonly used to prevent infections, is the cause of kidney disease...
Read Full NewsTelemedicine use is not associated with a substantial increase in mental health treatment among patients in rural, low-access, or distant communities, a new study shows.
A new analysis explores whether accelerating RT delivery with 6 fractions vs 5 fractions per week improves outcomes in patients with locally advanced HNSCC receiving concurrent chemotherapy.
Researchers have created nanoparticles that can remove disease-driving proteins while also delivering a chemotherapeutic or immunotherapeutic payload to cancer cells.
A population-based cohort study finds that an increased use of adjuvant systemic therapy can improve survival in patients with metachronous and synchronous bilateral breast cancer.
1.
Emicizumab in Infants With Hemophilia A: Safe and Effective Use.
2.
Long Wait Times on the Other Side of the Pond: King Charles' Cancer Diagnosis.
3.
Achieves a High Disease Control Rate in Head and Neck BCC with Vismodegib-RT Regimen.
4.
Cancer patients with HIV have demonstrated safety with immune checkpoint inhibitors.
5.
Guideline on management of early-stage non-small cell lung cancer released
1.
Exploring Innovative Solutions for Infantile Hemangioma Treatment
2.
Reshaping the Battlefield Through Tumor Microenvironment Modulation for Cancer Therapy
3.
The Danger of Rectus Sheath Hematoma: A Hidden Risk of Abdominal Surgery
4.
Revolutionizing Cancer Treatment with Darzalex: How an Innovative Drug is Transforming Lives
5.
The Benefits of Understanding Haptoglobin High: What You Need to Know
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
4.
Thromboprophylaxis In Medical Settings
5.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge